3-10142088-C-T
Variant summary
The NM_000551.4(VHL):c.241C>T (p.Pro81Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene VHL is a tumor suppressor gene (CancerMine: 345 TSG, 114 oncogene, 46 driver citations). The gene VHL is a known oncogene (CancerMine: 345 TSG, 114 oncogene, 46 driver citations). The gene VHL is a cancer driver gene (CancerMine: 345 TSG, 114 oncogene, 46 driver citations). The variant allele was found at a cumulative frequency of 0.000353 (AC=566) in the gnomAD database across 1,605,226 control chromosomes, including 1 homozygote. The grpmax filtering allele frequency (95% CI) is 0.000534. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★★). A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.P81L: Pathogenic/Likely_pathogenic (ClinVar VariationId 36899, 2 stars) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.P81A: Uncertain_significance (ClinVar VariationId 1068142, 1 star); p.P81= (synonymous): Benign/Likely_benign (ClinVar VariationId 3468038, 2 stars); p.P81= (synonymous): Benign/Likely_benign (ClinVar VariationId 2927601, 2 stars); p.P81= (synonymous): Benign (ClinVar VariationId 4071324, 1 star) This exact variant is established as oncogenic in: CGI (Cancer Genome Interpreter). The variant has been observed in cBioPortal in 7 samples across 2 studies and 7 cancer types; somatic enrichment level: SUPPORTING (Observed repeatedly in cBioPortal somatic datasets.). This exact variant is curated in the UniProt human variants database as Uncertain Significance, associated with Von hippel-lindau syndrome (vhl); it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_000551.4 missense
Scores
Clinical Significance
Conservation
Publications
- pheochromocytomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- von Hippel-Lindau diseaseInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, ClinGen, Genomics England PanelApp
- renal cell carcinomaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- autosomal recessive secondary polycythemia not associated with VHL geneInheritance: AR Classification: STRONG Submitted by: Ambry Genetics
- Chuvash polycythemiaInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Likely_pathogenic. The variant received 8 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O1Established oncogenic variant | CGI exact DNA-change oncogenic — Strong (O1); O1 contributing sources (4.0 pts): CGI (Cancer Genome Interpreter) | ||
| O4Enriched in somatic variant database | Enriched in cBioPortal (pre-computed score ≥ 1.0) — Supporting (O4); cBioPortal: samples=7 | studies=2 | cancer types=7 | level=SUPPORTING | points=1.0 | reason: Observed repeatedly in cBioPortal somatic datasets. | ||
| O5Same location/impact as known oncogenic | Different AA at same residue with oncogenic evidence (or germline P/LP in TSG), or same AA change SCI Tier II Potential — Supporting (O5); ClinVar same-AA oncogenic/T1: false | ClinVar same-AA SCI tier: — | CGI same-AA oncogenic: false | TSG: true | ClinVar same-AA germline P/LP: false | CIViC LOF: false | ClinVar diff-AA oncogenic: false | ClinVar diff-AA germline P/LP: true | ||
| O6Computational evidence supports deleterious effect | Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect | ||
| O7Mutational hotspot or critical domain | Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; No cancerhotspots.org hit at this position; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 39 pathogenic, 6 benign (OR vs. background: 30.4); Variant does not impact splicing — splice-hotspot path not applicable |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000551.4. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
VHL | MANE Select | c.241C>T p.Pro81Ser | missense | Exon 1 of 3 | Prot: NP_000542.1 UniProt: | |
VHL | c.241C>T p.Pro81Ser | missense | Exon 1 of 3 | Prot: NP_001341652.1 UniProt: | ||
VHL | c.241C>T p.Pro81Ser | missense | Exon 1 of 2 | Prot: NP_937799.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
VHL | TSL:1MANE Select | c.241C>T p.Pro81Ser | missense | Exon 1 of 3 | Prot: ENSP00000256474.3 UniProt: | |
VHL | TSL:1 | c.241C>T p.Pro81Ser | missense | Exon 1 of 2 | Prot: ENSP00000344757.2 UniProt: | |
VHL | TSL:1 | n.287C>T | non_coding_transcript_exon | Exon 1 of 3 | Prot: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.000348 | AC:53 | Hom:0 | AN:152206 | Cov:33 |
GnomAD2 exomes | AF: 0.000200 | AC:46 | AN:230188 | ||
GnomAD4 exome | AF: 0.000353 | AC:513 | Hom:1 | AN:1453020 | Cov:32 |
GnomAD4 genome | AF: 0.000348 | AC:53 | Hom:0 | AN:152206 | Cov:33 |
TOPMed (Bravo) | AF: 0.000348 | AC:92 | Hom:0 | AN:264690 | |
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.000598 | AC:140 | Hom:0 | AN:233924 | |
Local & regional cohorts 1 source | |||||
ESP6500 (Exome Variant Server) | AF: 0.000390 | AC:5 | AN:12808 | ||
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
ASC | 0.000834 * | 8 | 9598 | 0.000576 * | 6 | 10410 |
BipEx | 0.000598 | 17 | 28420 | 0.000381 | 11 | 28844 |
Epi25 | 0.000286 | 12 | 41958 | 0.000449 | 30 | 66888 |
SCHEMA | 0.000148 | 18 | 121784 | 0.000200 | 38 | 190432 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 24 | |
AlphaMissense | Pathogenic | 0.58 | |
BayesDel_addAF | Uncertain | 0.050 | T |
BayesDel_noAF | Pathogenic | 0.21 | |
CADD | Benign | 21 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Pathogenic | 0.91 | D |
Eigen | Uncertain | 0.23 | |
Eigen_PC | Uncertain | 0.28 | |
FATHMM_MKL | Uncertain | 0.87 | D |
FuncVEP CTI | Pathogenic | 0.71 | |
GPN-Star LLR | N/A | -7.0 | |
GPN-Star score | N/A | 7.0 | |
LIST_S2 | Uncertain | 0.87 | D |
M_CAP | Pathogenic | 0.99 | D |
MetaRNN | Uncertain | 0.55 | D |
MetaSVM | Pathogenic | 0.99 | D |
Mutation Taster | N/A | 7/93 | disease causing |
MutationAssessor | Benign | 1.7 | L |
PhyloP100 | Benign | 1.5 | |
popEVE | Benign | -3.2 | |
PrimateAI | Pathogenic | 0.88 | D |
PromoterAI | N/A | -0.042 | Neutral |
PROVEAN | Uncertain | -3.2 | D |
RBP_binding_hub_radar | N/A | 0.0 | |
RBP_regulation_power_radar | N/A | 1.7 | |
REVEL | Pathogenic | 0.68 | |
Sift | Benign | 0.038 | D |
Sift4G | Benign | 0.39 | T |
Varity_R | N/A | 0.81 | |
VESM-3B | Benign | -5.7 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.